⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

March 1, 2024Research and Practice in Thrombosis and HaemostasisOpen Access

Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial

Willian van Dijk Margaretha Prins Anna H.E. Roukens Geert V.T. Roozen Meta Roestenberg Leo G. Visser Astrid van Hylckama Vlieg Frits R. Rosendaal

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Fractional-dosed intradermal (i.d.) vaccination produces antibody concentrations above the proposed proxy for protection against severe disease as compared with intramuscular (i.m.) vaccination and may be associated with a decreased prothrombotic effect.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dijk et al. (2024) studied this question.

synapsesocial.com/papers/68e76353b6db6435876d9ac4 https://doi.org/10.1016/j.rpth.2024.102419

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines2024 · 3 citations
2Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose2024 · 7 citations
3A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccineRCT · 2021 · 225 citations
4Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adultsRCT · 2023 · 20 citations
5Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adultsother · 2020 · 1,504 citations
6Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.Human Clinical Trial · 2026
7Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trialLate-Phase Clinical Trial · 2022 · 101 citations
8Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled studyRCT · 2023 · 1 citations
9Perinatal outcomes of direct oral anticoagulant exposure during pregnancy: An analysis of the French pharmacovigilance databaseResearch and Practice in Thrombosis and Haemostasis · 2026
10Antithrombotic Strategies for Thrombosis Treatment and Thromboprophylaxis in Pediatric Cardiac Disease: A 20-Year Systematic Review of Prospective Studies and Clinical TrialsResearch and Practice in Thrombosis and Haemostasis · 2026

More from Research and Practice in Thrombosis and Haemostasis

More from Leiden University Medical Center